Research output per year
Research output per year
Fingerprint
Dive into the research topics where Gerrit Ossenkoppele is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party
Cloos, J., Valk, P. J. M., Thiede, C., Döhner, K., Roboz, G. J., Wood, B. L., Walter, R. B., Wang, S., Wierzbowska, A., Wei, A. H., Wu, D., Vergez, F., Venditti, A., van der Reijden, B. A., van de Loosdrecht, A. A., Tiong, I. S., Thol, F. R., Subklewe, M., Roumier, C. & Reuvekamp, T. & 26 others, , 12 Mar 2026, In: Blood. 147, 11, p. 1147-1167 21 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open AccessFile20 Downloads (Pure) -
Autologous stem cell transplantation versus consolidation chemotherapy as postremission treatment in newly diagnosed favorable- and intermediate-risk patients with AML: A comparative analysis of HOVON–SAKK–Nordic trials
Kotsos, D., Hazenberg, C., Pabst, T., Gradowska, P., Manz, M. G., Maertens, J., Graux, C., Vekemans, M.-C., Gjertsen, B. T., Lehmann, S. R., van Elssen, C. H. M. J., Valk, P. J. M., Vellenga, E., Ossenkoppele, G., löwenberg, B., Raaijmakers, M. H. G. P., Huls, G. & Versluis, J., 1 Aug 2026, In: HemaSphere. 10, 8, e70462.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Downloads (Pure) -
Machine learning provides individualized prediction of outcomes after first complete remission without allo-HSCT consolidation in adult acute myeloid leukemia—A HARMONY study
Hernández-Sánchez, A., Martínez Elicegui, J., Sträng, E., Benner, A., Sobas, M., Villaverde Ramiro, Á., Turki, A. T., Abáigar, M., Castellani, G., Versluis, J., Thomas, I., Tettero, J. M., Mecklenbrauck, R., Martínez-lópez, J., Pratcorona, M., Sanz, G., Voso, M. T., Lehmann, S. R., Röllig, C. & Metzeler, K. H. & 9 others, , 1 Sept 2026, In: HemaSphere. 10, 9, e70461.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Downloads (Pure) -
MDS/AML and AML with myelodysplasia-related gene mutations: clinical and molecular similarities
Boertjes, E. L., Grob, T., Al Hinai, A., Beverloo, B. H. B., Versluis, J., Kavelaars, F. G., Rijken, M., Compagne, K. G., Erpelinck, C. A. J., Sanders, M. A., Stoetman, E. C. G., Hanekamp, D., Gradowska, P. L., Ossenkoppele, G. J., Biemond, B. J., Manz, M. G., Pabst, T., Jongen-Lavrencic, M., löwenberg, B. & Valk, P. J. M., 24 Feb 2026, In: Blood. 10, 4, p. 939-950 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile20 Downloads (Pure) -
Prognostic value of measurable residual disease in high-risk MDS after intensive chemotherapy in HOVON-SAKK studies
Veenstra, C. R., Ngai, L. L., Gradowska, P., Versluis, J., Reuvekamp, T., Kelder, A., Scholten, W., Snel, S., Tettero, J. M., Bachas, C., Breems, D. A., Fischer, T., Gjertsen, B. T., Griskevicius, L., Juliusson, G., Maertens, J. A., Manz, M. G., Pabst, T., Passweg, J. R. & Porkka, K. & 7 others, , May 2026, In: HemaSphere. 10, 5, e70379.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile19 Downloads (Pure)
Press/Media
-
Prognostic relevance of limit of quantification as low-level cutoff for flow cytometry-based measurable residual disease assessment in acute myeloid leukemia
Haaksma, L. H., Reuvekamp, T., Tettero, J. M., Bachas, C., Ossenkoppele, G. J. & Cloos, J.
01/12/2025
1 Media contribution
Press/Media: other
-
CD34+CD38- leukemia stem cells predict clinical outcomes in acute myeloid leukemia patients treated non-intensively with hypomethylating agents
Reuvekamp, T., Mocking, T. R., Ossenkoppele, G. J., van de Loosdrecht, A. A., Bachas, C. & Cloos, J.
01/02/2025
1 Media contribution
Press/Media: other